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After publication of this article [1], it was noticed that 3
authors were missed from the author list. These authors
are Evripidis Lanitis, Melita Irving and George Coukos.
The correct author list can be seen above and updated
Competing Interests, Authors’ Contributions and Ac-
knowledgements can be seen below.
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